Christoffer Sejling

Christoffer Sejling

PhD fellow


Publication year:
  1. 2024
  2. Published

    Cancer risk in patients treated with denosumab compared with alendronate: A population-based cohort study

    Yahyavi, S. K., Holt, R., Knudsen, N. K., Andreassen, C. H., Sejling, Christoffer, Meddis, Alessandra, Kjær, Susanne Krüger, Schwarz, Peter, Jensen, Jens-Erik Beck, Torp-Pedersen, Christian, Juul, Anders, Selmer, Christian & Blomberg Jensen, M., 2024, In: Bone. 182, 8 p., 117053.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Self-reported and tracked nighttime smartphone use and their association with overweight and cardiometabolic risk markers

    Andersen, Thea Otte, Sejling, Christoffer, Jensen, Andreas Kryger, Dissing, A. S., Severinsen, E. R., Drews, Henning Johannes, Sørensen, Thorkild I.A., V Varga, Tibor & Rod, Naja Hulvej, 2024, In: Scientific Reports. 14, 1, 11 p., 4861.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. E-pub ahead of print
  5. 2023
  6. Published

    Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial

    Weis, Nina, Bollerup, S., Sund, J. D., Glamann, J. B., Vinten, C., Jensen, L. R., Sejling, Christoffer, Kledal, T. N. & Rosenkilde, Mette, 2023, In: Clinical Microbiology and Infection. 29, 10, p. 1313-1319 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published
  8. Published
  9. Published

    Nighttime Smartphone Use, Sleep Quality, and Mental Health: Investigating a Complex Relationship

    Andersen, Thea Otte, Sejling, Christoffer, Jensen, Andreas Kryger, Drews, Henning Johannes, Ritz, B., V Varga, Tibor & Rod, Naja Hulvej, 2023, In: Sleep. 46, 12, 12 p., zsad256.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 286674650